White Paper

The Scientific Risks of Commoditizing eCOA

The Scientific Risks of Commoditizing eCOA

Pages 10 Pages

IQVIA’s white paper warns against the commoditization of eCOA, stressing the need to balance technology with scientific rigor. While eCOA has improved compliance and data quality versus paper, an overemphasis on cost and speed risks undermining reliability. IQVIA integrates behavioral science, patient-centered design, and advanced tools like its Sculptor platform and 2,500+ pre-built COAs to enhance compliance and accuracy. Case studies show compliance rates up to 99% when science-driven implementation is applied. The paper concludes that investing upfront in scientifically robust eCOA design ensures fit-for-purpose solutions, reliable endpoints, and better patient outcomes.

Join for free to read